954 related articles for article (PubMed ID: 27286909)
1. Comparison of ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Hip Arthroplasty.
Churchill JL; Puca KE; Meyer ES; Carleton MC; Truchan SL; Anderson MJ
J Arthroplasty; 2016 Dec; 31(12):2795-2799.e1. PubMed ID: 27286909
[TBL] [Abstract][Full Text] [Related]
2. Comparing ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Knee Arthroplasty.
Churchill JL; Puca KE; Meyer E; Carleton M; Anderson MJ
J Knee Surg; 2017 Jun; 30(5):460-466. PubMed ID: 27699724
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
Bradley KE; Ryan SP; Penrose CT; Grant SA; Wellman SS; Attarian DE; Green CL; Risoli T; Bolognesi MP
Bone Joint J; 2019 Sep; 101-B(9):1093-1099. PubMed ID: 31474134
[TBL] [Abstract][Full Text] [Related]
4. Epsilon Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Hip and Total Knee Arthroplasty.
Hobbs JC; Welsby IJ; Green CL; Dhakal IB; Wellman SS
J Arthroplasty; 2018 Jan; 33(1):55-60. PubMed ID: 28939033
[TBL] [Abstract][Full Text] [Related]
5. Epsilon-aminocaproic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study.
Riaz O; Aqil A; Asmar S; Vanker R; Hahnel J; Brew C; Grogan R; Radcliffe G
J Orthop Traumatol; 2019 Jul; 20(1):28. PubMed ID: 31321578
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic versus aminocaproic acids in patients with total hip arthroplasty: a retrospective study.
Xie H; Yang YS; Tian SM; Wang BJ; Fu WM; Cheng LL; Jiang NN; Gu G; Zhao DW
BMC Musculoskelet Disord; 2022 Nov; 23(1):999. PubMed ID: 36401231
[TBL] [Abstract][Full Text] [Related]
7. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
[TBL] [Abstract][Full Text] [Related]
8. Blood Conservation Using Tranexamic Acid Is Not Superior to Epsilon-Aminocaproic Acid After Total Knee Arthroplasty.
Boese CK; Centeno L; Walters RW
J Bone Joint Surg Am; 2017 Oct; 99(19):1621-1628. PubMed ID: 28976426
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of tranexamic acid in routine performance of total knee replacement surgery].
Camarasa Godoy MA; Serra-Prat M; Palomera Fanegas E
Rev Esp Anestesiol Reanim; 2008 Feb; 55(2):75-80. PubMed ID: 18383968
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid versus aminocaproic acid for blood management after total knee and total hip arthroplasty: A systematic review and meta-analysis.
Liu Q; Geng P; Shi L; Wang Q; Wang P
Int J Surg; 2018 Jun; 54(Pt A):105-112. PubMed ID: 29723672
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid versus aminocapróic acid in multiple doses via the oral route for the reduction of postoperative bleeding in total primary hip arthroplasty: a prospective, randomized, double-blind, controlled study.
Morales-Avalos R; Ramos-Morales T; García-Pedro JA; Espinoza-Galindo AM; Acosta-Olivo C; Morcos-Sandino M; Silva-Ramos HNG; Peña-Martínez VM; Rodríguez-Torres RA; Vilchez-Cavazos F
Blood Coagul Fibrinolysis; 2021 Mar; 32(2):132-139. PubMed ID: 33443925
[TBL] [Abstract][Full Text] [Related]
12. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Moxey AJ; Carless PA; O'Connell D; McClelland B; Henderson KM; Sly K; Laupacis A; Fergusson D
Cochrane Database Syst Rev; 2001; (1):CD001886. PubMed ID: 11279735
[TBL] [Abstract][Full Text] [Related]
13. Combination of Intravenous and Intra-Articular Application of Tranexamic Acid and Epsilon-Aminocaproic Acid in Primary Total Knee Arthroplasty: A Prospective Randomized Controlled Trial.
Zheng C; Ma J; Xu J; Si H; Liu Y; Li M; Shen B
Orthop Surg; 2023 Mar; 15(3):687-694. PubMed ID: 36575630
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of epsilon aminocaproic acid (EACA) as an antihemorrhagic drug in bilateral one stage total knee arthroplasty: A double-blind randomized controlled trial.
Tripathy SK; Rao PB; Nanda SN; Nayak C; Samal BP; Jain M; Srinivasan A; Hota D
Knee; 2020 Jan; 27(1):229-234. PubMed ID: 31882387
[TBL] [Abstract][Full Text] [Related]
15. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
[TBL] [Abstract][Full Text] [Related]
16. Antifibrinolytics reduce blood loss in adult spinal deformity surgery: a prospective, randomized controlled trial.
Peters A; Verma K; Slobodyanyuk K; Cheriyan T; Hoelscher C; Schwab F; Lonner B; Huncke T; Lafage V; Errico T
Spine (Phila Pa 1976); 2015 Apr; 40(8):E443-9. PubMed ID: 25868100
[TBL] [Abstract][Full Text] [Related]
17. Effect of Antifibrinolytic Therapy on Complications, Thromboembolic Events, Blood Product Utilization, and Fusion in Adult Spinal Deformity Surgery.
Soroceanu A; Oren JH; Smith JS; Hostin R; Shaffrey CI; Mundis GM; Ames CP; Burton DC; Bess S; Gupta MC; Deviren V; Schwab FJ; Lafage V; Errico TJ
Spine (Phila Pa 1976); 2016 Jul; 41(14):E879-E886. PubMed ID: 27398796
[TBL] [Abstract][Full Text] [Related]
18. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
Demos HA; Lin ZX; Barfield WR; Wilson SH; Robertson DC; Pellegrini VD
J Arthroplasty; 2017 Aug; 32(8):2375-2380. PubMed ID: 28343823
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis.
Li G; Sun TW; Luo G; Zhang C
Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279
[TBL] [Abstract][Full Text] [Related]
20. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
